New Mexico Educational Retirement Board’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12M Buy
5,000
+200
+4% +$136K 0.08% 240
2026
Q1
$3.71M Hold
4,800
0.11% 153
2025
Q4
$3.71M Buy
4,800
+100
+2% +$67.9K 0.11% 147
2025
Q3
$2.64M Sell
4,700
-200
-4% -$113K 0.08% 226
2025
Q2
$2.57M Hold
4,900
0.08% 218
2025
Q1
$3.11M Sell
4,900
-200
-4% -$138K 0.11% 156
2024
Q4
$3.63M Sell
5,100
-100
-2% -$83.9K 0.12% 133
2024
Q3
$5.47M Sell
5,200
-200
-4% -$223K 0.18% 85
2024
Q2
$5.68M Hold
5,400
0.2% 81
2024
Q1
$5.2M Sell
5,400
-200
-4% -$190K 0.19% 91
2023
Q4
$4.92M Hold
5,600
0.19% 94
2023
Q3
$4.61M Buy
5,600
+400
+8% +$314K 0.2% 88
2023
Q2
$3.74M Buy
5,200
+200
+4% +$154K 0.16% 103
2023
Q1
$4.11M Sell
5,000
-100
-2% -$75.4K 0.21% 89
2022
Q4
$3.68M Sell
5,100
-400
-7% -$295K 0.2% 99
2022
Q3
$3.79M Sell
5,500
-400
-7% -$252K 0.21% 88
2022
Q2
$3.49M Sell
5,900
-300
-5% -$195K 0.17% 113
2022
Q1
$4.33M Sell
6,200
-200
-3% -$127K 0.16% 108
2021
Q4
$4.04M Sell
6,400
-500
-7% -$307K 0.14% 126
2021
Q3
$4.18M Sell
6,900
-100
-1% -$62.1K 0.15% 123
2021
Q2
$3.91M Buy
7,000
+600
+9% +$304K 0.13% 131
2021
Q1
$3.03M Hold
6,400
0.12% 147
2020
Q4
$3.09M Sell
6,400
-100
-2% -$54K 0.13% 136
2020
Q3
$3.64M Sell
6,500
-300
-4% -$182K 0.17% 108
2020
Q2
$4.24M Buy
6,800
+1,800
+36% +$1.02M 0.2% 90
2020
Q1
$2.44M Sell
5,000
-1,100
-18% -$454K 0.15% 133
2019
Q4
$2.29M Hold
6,100
0.1% 197
2019
Q3
$1.69M Sell
6,100
-300
-5% -$88.8K 0.08% 262
2019
Q2
$2M Sell
6,400
-100
-2% -$33.3K 0.09% 228
2019
Q1
$2.67M Sell
6,500
-100
-2% -$41.2K 0.11% 175
2018
Q4
$2.46M Sell
6,600
-300
-4% -$110K 0.12% 170
2018
Q3
$2.79M Sell
6,900
-200
-3% -$76.1K 0.11% 185
2018
Q2
$2.45M Sell
7,100
-200
-3% -$62.5K 0.1% 206
2018
Q1
$2.51M Sell
7,300
-100
-1% -$34.8K 0.1% 219
2017
Q4
$2.78M Buy
7,400
+300
+4% +$122K 0.11% 190
2017
Q3
$3.17M Hold
7,100
0.15% 164
2017
Q2
$3.49M Sell
7,100
-600
-8% -$263K 0.17% 142
2017
Q1
$2.98M Sell
7,700
-400
-5% -$148K 0.14% 182
2016
Q4
$2.97M Buy
8,100
+200
+3% +$76.1K 0.14% 182
2016
Q3
$3.18M Sell
7,900
-1,200
-13% -$481K 0.16% 158
2016
Q2
$3.18M Buy
9,100
+500
+6% +$193K 0.14% 169
2016
Q1
$3.1M Buy
8,600
+200
+2% +$82.4K 0.15% 164
2015
Q4
$4.56M Sell
8,400
-200
-2% -$108K 0.22% 113
2015
Q3
$4M Buy
8,600
+800
+10% +$430K 0.2% 129
2015
Q2
$3.98M Sell
7,800
-800
-9% -$390K 0.19% 136
2015
Q1
$3.88M Sell
8,600
-300
-3% -$127K 0.17% 152
2014
Q4
$3.65M Sell
8,900
-1,000
-10% -$393K 0.15% 166
2014
Q3
$3.57M Sell
9,900
-400
-4% -$134K 0.14% 171
2014
Q2
$2.91M Hold
10,300
0.12% 210
2014
Q1
$3.09M Buy
+10,300
New +$3.17M 0.13% 191
2013
Q3
Sell
-12,100
Closed -$2.72M 904
2013
Q2
$2.72M Buy
+12,100
New +$2.82M 0.11% 211

Other funds holding REGN

New Mexico Educational Retirement Board's REGN Position: Q2 2026 in Review

New Mexico Educational Retirement Board increased its Regeneron Pharmaceuticals (REGN) stake by 4.2% in Q2 2026, buying an estimated $136K and bringing the position to 5,000 shares worth $3.12M. The position accounts for 0.08% of the portfolio, ranked #240.

New Mexico Educational Retirement Board first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.68M in Q2 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • New Mexico Educational Retirement Board held 5,000 shares of Regeneron Pharmaceuticals worth $3.12M as of Q2 2026.
  • New Mexico Educational Retirement Board bought 200 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $136K.
  • Regeneron Pharmaceuticals made up 0.08% of New Mexico Educational Retirement Board's portfolio in Q2 2026, its #240 holding.
  • New Mexico Educational Retirement Board first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • New Mexico Educational Retirement Board's Regeneron Pharmaceuticals position peaked at $5.68M in Q2 2024.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on New Mexico Educational Retirement Board's 13F filing for Q2 2026, filed 29 Jul 2026.